Healthcare

NRx Pharmaceuticals is bolstering its executive team with a strategic hire aimed at accelerating the development of novel neuroplastic treatments....

The coming year represents a critical juncture for Viking Therapeutics, a biotechnology firm whose clinical pipeline is drawing significant investor...

Following a strategic realignment, IntelGenx is now channeling its efforts toward advancing its product pipeline and expanding manufacturing capabilities. The...

Axsome Therapeutics is embarking on a significant commercial and regulatory push. The biopharmaceutical company aims to solidify its position in...

A significant legal challenge has been resolved in favor of Abbott Laboratories. This week, a U.S. federal court issued a...

Investor confidence in Johnson & Johnson is strengthening, fueled by a significant regulatory milestone that adds momentum to the stock's...

Eli Lilly has provided a more definitive timeline for one of its most anticipated pipeline assets. During a presentation at...

In a strategic move during a period of intense focus on profitability in the health insurance sector, UnitedHealth Group has...

The healthcare giant Abbott Laboratories has taken a decisive step toward completing the largest acquisition in its corporate history. To...

After a punishing multi-month decline, shares of telehealth provider Hims & Hers are showing tentative signs of life. This nascent...